Pharmacy Reverse Distribution Service
Closed Pre-Solicitation Posted
- Solicitation number
- SS75H70926BAO_055
- Agency
-
Indian Health Service
Department of Health and Human Services
- Responses due
- Set-aside
- Indian Small Business Economic Enterprise
Opportunity facts
- NAICS code
- 562211 Hazardous Waste Treatment and Disposal
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Indian Health Service intends to solicit pharmaceutical reverse distribution services under a Buy Indian Act set-aside for Indian Small Business Economic Enterprises, with capability statements due June 8, 2026. This is a sources sought notice, not a solicitation; responses should demonstrate DEA registration, past healthcare facility reverse distribution experience, and Indian Economic Enterprise eligibility requiring Indians or Indian Tribes to receive at least 51% of contract earnings and control management and daily operations.
Place of performance spans five Billings Area IHS service units in Montana: Blackfeet Community Hospital, Crow/Northern Cheyenne Hospital, Fort Belknap Hospital, Fort Peck Service Unit facilities, and Northern Cheyenne Service Unit. Services are performed three times annually and include on-site removal and return of expired and soon-to-expire pharmaceuticals (controlled and non-controlled) to authorized manufacturers or wholesalers, with all labor, equipment, materials, packaging, and transportation provided by the contractor at no charge.
The contractor must maintain DEA registration as a reverse distributor, comply with IHS Manual Section 3-7.6C, the Controlled Substances Act, and 21 CFR Parts 1300–1321, and document chain-of-custody for controlled substances with DEA Form 222 and destruction certificates. Deliverables include detailed inventory reports, compliant packaging, prepaid shipping labels, and reconciliation documentation within 60 days of shipment. Returns credits must be applied to the pharmacy vendor account within 120 days; invoices are submitted electronically through the Invoicing Processing Platform within 30 workdays of service.
The contract covers one base year (June 1, 2026–May 31, 2027) plus four optional one-year renewals through May 31, 2031. Work is classified under NAICS 562211 (Hazardous Waste Treatment and Disposal) and PSC 6505 (Drugs and Biologicals). Submit capability statements and the Buy Indian Act Indian Economic Enterprise Representation Form to teri.kittson@ihs.gov by June 8, 2026 at 3:00 pm MST, referencing Sources Sought ID SS-75H70926BAO_055.
Notice text
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, Indian Health Service must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable.
The Government is seeking to identify Indian Small Business Economic Enterprises (ISBEEs), Indian Economic Enterprises (IEE) capable of performing the below Indian Health Services (IHS) requirement. Any vendor responding to this notice should submit their capability statement as well as the Buy Indian Act Indian Economic Enterprise Representation Form (attached).
Consistent with the revised Buy Indian Act, HHS/IHS adopted the definition of an Indian Economic Enterprise (IEE) set forth in 48 CFR 1480.201. This definition includes the following requirement, amongst others: "the Indians or Indian Tribes must, together, receive at least a majority of the earnings from the contract.”
Files
| File | Type | Posted |
|---|---|---|
| Sources Sought.pdf | ||
| IEE Representation Form.pdf | ||
| SOW_Pharmaceutical Reverse Distribution Services.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity